Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:15 PM
Ignite Modification Date:
2025-12-25 @ 7:49 PM
NCT ID:
NCT00423735
Group ID:
EG001
Title:
Stage 1B: Dasatinib up to 400mg/Day
Description:
Patients begin with oral 100mg dasatinib twice daily on days 1-28. Courses repeat every 28 days in the absence of disease progression and unacceptable toxicity. Patients could escalate 50mg/day at each new cycle up to 400mg/day if they had not progressed to date and had not experienced dose-limiting toxicity.
dasatinib: Given orally
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
14
Serious Number At Risk:
29
Other Number Affected:
23
Other Number At Risk:
29
Study:
NCT00423735
Results Section:
NCT00423735
Adverse Events Module:
NCT00423735